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Abstract
Motivation: A fundamental problem for disease treatment is that while antibiotics are a powerful counter to
bacteria, they are ineffective against viruses. Often, bacterial and viral infections are confused due to their
similar symptoms and lack of rapid diagnostics. With many clinicians relying primarily on symptoms for
diagnosis, overuse and misuse of modern antibiotics are rife, contributing to the growing pool of antibiotic
resistance. To ensure an individual receives optimal treatment given their disease state and to reduce over-
prescription of antibiotics, the host response can in theory be measured quickly to distinguish between
the two states. To establish a predictive biomarker panel of disease state (viral/bacterial/no-infection) we
conducted a meta-analysis of human blood infection studies using Machine Learning (ML).
Results: We focused on publicly available gene expression data from two widely used platforms, Affymetrix
and Illumina microarrays as they represented a significant proportion of the available data. We were able
to develop multi-class models with high accuracies with our best model predicting 93% of bacterial and
89% viral samples correctly. To compare the selected features in each of the different technologies, we
reverse engineered the underlying molecular regulatory network and explored the neighbourhood of the
selected features. The networks highlighted that although on the gene-level the models differed, they
contained genes from the same areas of the network. Specifically, this convergence was to pathways
including the Type I interferon Signalling Pathway, Chemotaxis, Apoptotic Processes, and Inflammatory /
Innate Response.
Availability: Data and code are available on the Gene Expression Omnibus and github.
Contact: philipp.antczak@uk-koeln.de
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction
The varying differences within both classes of bacterial and viral infecti-
ons cause the body to respond in a distinct way (Shi and Gewirtz, 2018).
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Bacteria can be countered by pathways such as complement-mediated
lysis, and the cell-mediated response for those that survive phagocytosis
and live within the cell (intracellular bacteria). In this response, cells pre-
sent bacterial peptides (antigens) on their surface, which are identifiable by
Helper T cells that mediate bacterial destruction (Chaplin, 2010). There
are a large variety of viruses and bacteria that affect the host’s immune
system in various ways. Whilst some response pathways may overlap for
bacterial and viral infections, there are however a number key differences
(Rock et al., 2016; Yewdell and Bennink, 1999). In fact, these different
response pathways cause varied transcription (expression) of key genes
and, as such, can provide a basis for distinguishing disease state based
on the host’s transcriptional response (Manger and Relman, 2000). Such
knowledge can be exploited in differentiating between viral, bacterial and
control biological states. A previous study demonstrated this by deve-
loping a small set of only seven genes that can accurately discriminate
bacterial from viral infections across a range of clinical conditions, whilst
simultaneously succeeding to determine with high accuracy which pati-
ents do not require antibiotics (Sweeney et al., 2016). Simultaneously,
there have been numerous other studies looking at diagnosing infection
based on the host’s transcriptional response (Ramilo et al., 2007; Hu et al.,
2013; Nascimento et al., 2009; Zaas et al., 2009; Dawany et al., 2014).
Previous work failed to generalise as the data contains a far smaller set of
pathogens than would be encountered in ‘real world’ scenarios, or studies
focussed on single technology platforms, specific pathogens, or geogra-
phical regions (which contain populations with different HLA alleles, and
different local pathogen groups). To address this lack of generalisation,
this work aims to utilise a larger scale analysis over a more representative
sample set to improve biomarker generalisability. To gain statistical power
and develop more robust panels, meta analyses of publicly available data
have proven to be an effective technique (Lagani et al., 2016). However,
analysis integrating several cohorts together face inherent limitations from
systematic variations otherwise known as “batch effects”. Without proper
handling, these batch effects have been demonstrated to be detrimental
in population level gene expression analysis (Akey et al., 2007). Data-
driven identification of robust biomarkers is a much-debated subject in the
biological field. Several machine learning (ML) approaches have been pro-
posed, with typically good performance on data sets used in a given study,
but poorer performance when biomarkers are taken forward for validation.
This is mainly due to lack of external validation or inherent cross-validation
approaches used during the model optimisation process. Important is the
distinction between uni- and multi-variate approaches to biomarker disco-
very. While identifying a single predictive marker might be preferred in
theory, multi-variate approaches have enabled the discovery of more com-
plex relationships that can provide performance (sensitivity; specificity)
far exceeding univariate predictive models (Trevino and Falciani, 2006)
including features embedded in specific regions of an underlying mole-
cular interaction network improving biological insight into physiological
responses (Ortega et al., 2008). One particular aspect in multi-variate pre-
dictive approaches is the optimisation of the representative model, which
rarely can be achieved through brute force testing and relies on feature
selection algorithms. In this publication we focus on the use of the Ran-
dom Forest (RF) (Breiman, 2001) classifier, which has been demonstrated
to perform well in real-world classification problems with high dimensi-
onality and biased data (Denil et al., 2014). RFs are bagged decision tree
models, which classify data points on a subset of features and have been
praised for their ability to avoid overfitting (Segal, 2004). Unlike Support
Vector Machines or Neural Networks (two frequently used models with
high predictive capabilities) RFs forego much of the model selection step
using an ensemble approach which builds many weak classifiers into a sin-
gle strong self-averaging, interpolating model (Cawley and Talbot, 2010).
Whilst RFs consist of many weaker models, they have been shown highly
effective at capturing non-linear relationships between model predictors
and outputs in a number of genomic studies (Díaz-Uriarte and Alvarez de
Andrés, 2006; Jiang et al., 2004). Feature selection can vastly improve
these ML models by removing and reducing the overall complexity of the
data, increasing the statistical power, faster computational implementa-
tion, and removing the overall noise (Iguyon and Elisseeff, 2003). Various
feature selection procedures exist and have been demonstrated in biologi-
cal problems (Saeys et al., 2007). For this study we focused on Backwards
Elimination (BW) for gene expression data (Díaz-Uriarte and Alvarez de
Andrés, 2006) forming a well-established benchmark, and an evolutio-
nary algorithm, a more explorative and parameterizable search approach,
to obtain smaller feature sets (Trevino and Falciani, 2006). BW essenti-
ally searches for the optimal feature set by progressively eliminating the
least important features from a given dataset and testing whether the new
model is significantly more accurate than the previous. Whereas evoluti-
onary algorithms are based on evolving population(s) of models, which
are repetitively intermixed, and subject to random point mutations. This
evolutionary process is assumed to produce converging model populations
in terms of performance and their associated feature sets (de la Fraga and
Coello Coello, 2011). In this publication, we focus on the development of
predictive models able to distinguish viral, bacterial, and no infection sam-
ples using publicly available transcriptomics data (human blood samples
where individuals had bacterial, viral or no infection), from two microarray
technologies (Affymetrix and Illumina). We applied a BW and evolutio-
nary algorithm to these data to identify models predictive of infection status
and compared the results in a biological context by exploring the neighbou-
rhoods of these genes. These network representations show that while the
technologies develop different models, selection occurs in similar functio-
nal space, highlighting the robustness of our models. We further validated
our models by evaluating the top models across the two technologies.
2 Methods
2.1 Data Integration
To identify and validate a panel of biomarkers able to differentiate bacte-
rial and viral infections, we performed a meta-analysis of GEO gene
expression data, all from open source microarray human blood infe-
ction studies. Our analysis was divided into three major method steps:
i) pre-processing, ii) feature selection, and iii) inferring a gene interaction
network, to discover and validate gene lists (1). Following the major steps,
we performed and report the results of a final out-of-sample test on data
not previously used in the training phase for greater validation. All code
is available on github (https://github.com/PGB-LIV/Classifying-disease-
state-in-high-dimensional-data).
Data. Datasets from Affymetrix and Illumina platforms, consisting
of 3868 samples, from 21 different studies, were included in the analysis
(Table 1 – available on GEO under GSE162329 and GSE162330). Sele-
ction criteria included: study set size, class pathogen strain distribution,
and ability to integrate the data. Studies for which there were ambigu-
ous annotations (possible bacterial (b?) viral (v?)) were incorporated (an
analysis for confirmed cases only is shown in Section S2). To integrate the
data, ProbeIDs were substituted by their gene mappings and deduplicated
by selecting the ProbeID/gene combination with the highest average inten-
sity across samples (Wang et al., 2012). Data from each manufacturer was
batch corrected to remove inter-platform and intra platform batch effects
using ComBat (Johnson et al., 2007) in a two-step sequential batch cor-
rection pipeline (Section S1). For intra platform batch correction, "study
ID" was passed as the batch and "sample classes" were used as covariates.
For the inter platform batch correction, "series" (platform GPL) was pro-
vided as the batch variable with no additional covariates. Batch correction
success was estimated by calculating the significance of the overlap of
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differential gene expression results pre and post batch as well as through
principal component analysis (PCA) (Pearson, 1901).
Feature Selection. Two feature selection procedures: (i) a Backward
Elimination process (Huang et al., 2009), and (ii) a genetically inspired
search algorithm (GALGO) (Trevino and Falciani, 2006) were used. Both
search procedures operated using the RF Classifier, implemented in the
R Ranger package (Wright and Ziegler, 2017). Datasets were fed into
these approaches with their full class list (bacterial/viral/no infection) and
a single predictive model requested. Depending on the feature selection
strategy this included different steps described below. For both a study
aware data split and smaller class penalty Breiman (2001) was used to
ensure best possible model development. In both cases the reported results
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Fig. 1. Conceptual overview. Individual data (A), containing bacterial (b), viral (v), control
(c), and samples with lower levels of study confidence (?s) are merged. (B) combined
and batch corrected dataset. Feature selection is performed on data B in Step 2 using (i)
Backwards Elimination, and (ii) an Evolutionary algorithm. (C) Gene Lists obtained in the
feature selection. Data B is also used to infer and cluster a gene interaction network, by (i)
reverse engineering the gene interaction network, and (ii) clustering the adjacency matrix.
(D) The clustered interaction network overlaid with genes found in the best performing
model of each dataset and search procedure.
Backward Elimination. A 60/20/20 training/test/evaluation data split
was used in BW, with 60 used for model training, 20 used to select trai-
ned models, then a final 20 as a “held out” subset for final evaluation and
reporting, a standard technique in machine learning (Hastie et al., 2009).
For each dataset we ran 240 BW search procedures, using Out-of-bag
(OOB) error as the minimisation criterion and implementation using the
VarSelRF R package (Diaz-Uriarte, 2007). Each run generated a single
optimal model which minimised OOB. For each dataset a single represen-
tative model was selected from the 240 runs which maximised accuracy
on test data.
Genetic-algorithm. The Genetic-Algorithm (GA) optimized appro-
ach is an efficient method for creating suitable multivariate models. We
used the R library GALGO (Trevino and Falciani, 2006) to identify a small
feature model by continuously crossing a number of small feature models
(chromosomes of features) with each other, hypothetically identifying bet-
ter models with successive generations and repeating this procedure several
times. We used an initialised fitness goal of 0.95, model size (chromosome
size) of 15 genes, and k-fold cross-validation to counter overtraining. Simi-
lar to the BW approach, GALGO uses a multiple split strategy (Trevino
and Falciani, 2006). 250 models were generated for each dataset and a
representative model established through a frequency based forward sele-
ction strategy which ensures only genes that contributed to predictions are
included in the final model (Section S2).
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615 (100) 834 (100) 268 (100) 2151 (100)
Bacterial
(b) (%)




227 (36.9) 0 (0) 0 (0) 141 (6.6)
Viral (v)
(%)




0 (0) 348 (41.7) 119 (44.4) 0 (0)
Control (c)
(%)
156 (25.4) 68 (8.2) 17 (6.3) 467 (21.7)
Other (%) 41 (6.7) 0 (0) 0 (0) 259 (12)
2.2 Inferring underlying interaction network
Gene regulatory networks were developed using ARACNe (Margolin et al.,
2006) (Figure 1). To select significant interactions within our dataset we
used a p-value threshold < 0.05 in the ARACNe procedure. Networks were
loaded into Cytoscape (Shannon et al., 2003) and visualised. To identify
highly interconnected sub-networks within our reconstructed regulatory
network we utilised the Cytoscape clustering plugin GLay (Su et al., 2010)
to implement the divisive Girvan-Newman algorithm which removes edges
based on betweenness (Newman, 2006). This resulted in a number of smal-
ler sub-networks and allowed us to inspect their functional roles within
the larger network. DAVID was used to map higher level ontologies on
these subnetworks (Huang et al., 2007). For clusters of genes with enri-
ched and significant terms related to the immune response, we labelled
them manually as Functionally Relevant (FR) clusters. These FR clusters
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allowed us to make inferences about which biological functions hold pre-
dictive power, by overlaying model selected genes onto our labelled gene
regulatory network.
2.3 Out of sample testing
To validate the models obtained by feature selection within the Affymetrix
and Illumina datasets, we tested their predictive ability in the other data-
set. Briefly, in the case of the Affymetrix optimised model, we extract the
best performing genes and retrained and tested the RF classifier using the
Illumina dataset with a 60/40 training/test split. For an Illumina optimi-
sed model we followed the same principle but on the Affymetrix dataset.
These non-discovery datasets contained samples from different studies and
technology and therefore represented the ideal validation datasets. With
similar error between discovery and non-discovery data one can be confi-
dent that models have not overfitted to a given dataset and are suggested
to be generalisable.
3 Results
3.1 Integrating data across multiple platforms
The final datasets contained 19,947 and 13,383 distinct genes for the Illu-
mina and Affymetrix datasets respectively. The lower Affymetrix count
was due to platforms GPL571 and GPL9188 which only contained 13,383
genes (Table 1). Manufacturer relevant datasets were merged successfully
(Figure S2). The resulting two datasets Affy_I and Illumina_I contained
1676 and 1892 samples respectively. Both datasets contained more than
50% viral samples with bacterial samples the most underrepresented class
(Table 1).
Table 2. Merged and batch corrected modelling dataset description. Merged
and batch corrected Affymetrix and Illumina (ambiguous classes integrated)






























3.2 Identifying biomarker panels predictive of viral,
bacterial, and no-infection
A backward selection (BW) and genetic algorithm based approach (GA)
were applied to the resulting data. To compare the selection strategies
between the two approaches, genes were ranked and their relative gene
selection frequencies computed (Table 3). BW search procedures in both
technologies converged to a small set of genes. For Affymetrix 14 were
included at a rate of 1.0, whereas for Illumina BW results contain 12 genes
at a rate of 1.0 (Table 3). GA’s on the other hand contained a much wider
gene selection in the evolved chromosome, in both manufacturers only a
single gene was included at a relative rate of 1.0. Overall search results
(aggregated between runs by frequency) from BW and GA in both Affyme-
trix and Illumina all contained LY6E (Lymphocyte antigen 6E, UniProt:
Q16553) amongst their 9 most frequently selected genes. IFI27 (Inter-
feron alpha-inducible protein 27, mitochondrial, UniProt: P40305) and
IFI44 (Interferon-induced protein 44, UniProt: Q8TCB0), also had high
selection frequencies for three of the four search procedures (Table 3).
These 3 genes (LY6E, IFI27, and IFI44) are all type-I interferon-inducible
genes (ISGs), demonstrated to have altered expressions in disease states,
and known to be highly effective at countering infection (Rönnblom and
Eloranta, 2013; Schneider et al., 2014; McNab et al., 2015; Kyogoku et al.,
2013). Many of the other frequently selected genes have been previously
linked to disease state in literature. MS4A4A, IFI44L, OAS2, and IFIT5 are
known ISGs; increased levels of MMP8 have been observed in HIV viral
studies (Singh et al., 2018); SIGLEC1, a Type 1 transmembrane protein,
is expressed by a subpopulation of macrophages found upregulated during
in vivo respiratory syncytial virus infections (Jans et al., 2018) and con-
tributes to the initiation of formation of the virus-containing compartment
(Hammonds et al., 2017).
Table 3. Top 16 Gene selection for Affymetrix and Illumina models and their
relative selection frequencies. Frequency provided in brackets is based on
the model selection frequency in each optimisation run (the number of times
a gene was selected across the number of optimised models). Bold genes
are included amongst 3 of models top 16 selection, and underlined genes
are included in all four.
Affymetrix Genes (relative frequency) Illumina (relative frequency)
















CD177 (1.00) LY6E (0.39)
TSPO (1.00) CDC27 (0.66) GPR84 (1.00) SPATS2L
(0.34)
LY6E (1.00) TSPO (0.56) EIF1 (1.00) RSAD2
(0.26)



























IFI44 (0.44) EEF2 (1.00) MCEMP1
(0.19)






















To further investigate gene convergence, we compared the relative
model gene inclusion rates for all search procedures together. Figure 2
shows the resulting stacked frequency, where 88 genes are visualised
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Model Gene Selection Frequency
Fig. 2. Gene frequency in Affymetrix and Illumina models. Each Model frequency is scaled between 1 and 25. Model overlapping gene frequencies are then stacked and coloured by
model-dataset combination. Affymetrix Models by shades of blue and Illumina models by shades of red.
which had greater than 5% aggregated inclusion across all search pro-
cedures (Table S38). This highlighted LY6E, IFI27, and CD177 as
important key genes. CD177 is a neutrophil-specific receptor known to
be at increased expression for patients in septic shock (Demaret et al.,
2016; Stroncek, 2007). To better compare the models, we performed a
functional enrichment analysis of these 88 intersecting genes between the
two manufacturers’ models. We found both highly enriched and significant
terms relating to the immune response: ‘Antiviral defense’ comprising of
12 genes, the ‘type I interferon signalling pathway’ which included 10
genes, and ‘Immunity’ encompassing 17 genes (Figure 3). Final represen-
tative models were developed (Affy_BW, Affy_GA, Illumina_BW, and
Illumina_GA) and evaluated on their performance on a held-out data
split. Model performance was recorded as the size of the gene list and
its class-based performance in terms of: Balanced Accuracy, Sensitivity,
Specificity, and Mcnemar’s Test p-value which tests for consistency in
responses and can reveal bias to classifying a certain class (Dietterich,
1998) (full results included in S2 Biomarker search results). Average model
size was similar between both Affymetrix and Illumina models (30-37
genes) (Table 4). On average models classified 0.89 of Bacterial, 0.72 of
Control and 0.86 of Viral classes correctly across all datasets. In particular,
the Affymetrix models, BW and GA, performed particularly well in terms
of balanced accuracy on bacterial samples (0.94 and 0.93 respectively).
In terms of sensitivity all models performed well for bacterial and viral
classes (on average 0.85, and 0.93 respectively), however control sample
performance was worse when compared to the viral and bacterial classes
(0.57). Evaluating model specificity, bacterial classification performance
was particularly high over all models (averaging 0.95) which would sug-
gest we can identify bacterial samples particularly well regardless of the
model used.
3.3 Inferred interaction networks
GLay clustering of the Illumina gene interaction network initially revealed
14 clusters containing more than 10 genes (Figure 4 – see Section S3
for the Affymetrix based analysis). To enable a more granular analysis of
specific network sections (those indicated to be functionally relevant in the
immune response (FR) as indicated by enrichment analysis, or containing
genes selected by our models) we further partitioned several of the initial
clusters, forming a network hierarchy (limited to a depth of 3). This resulted
in 110 distinct groups of genes which we analysed (Table 5). In the Illumina
data derived results, 24 of the 110 clusters were marked as FR (Table 5),
of these, 10 FR clusters contained genes selected by an Illumina optimal
model. In total 55 genes from the Illumina optimal models were found
in these 10 FR clusters (68% of all the 81 Illumina model selected genes
found in the network). Additionally, a small number of clusters (four) were
selected by every optimal Illumina model.
Affymetrix – Illumina cluster comparison. We found a similar num-
ber of clusters converged between both Affymetrix and Illumina-derived
gene lists in their respective networks (Section S3). Importantly, the clu-
sters were identified using an approach that tests for increased connectivity
within the network, and as such, modules containing highly co-expressed
genes are identified. Separate clusters therefore represent features that
are further away from each other. The observed convergence therefore
suggests that the RF models are selecting features from particular gene
functional units within our network. Interestingly, the gene level conver-
gence is more heterogenous likely due to technical differences between the
technologies. For greater biological understanding we compared the most
selected clusters from both the Affymetrix and Illumina Interaction Netw-
ork. In Illumina this was Cluster 3.1.3 (Section S3). Whilst the size between
both clusters was not comparable (Affymetrix – Cluster 5 being 435 Genes
and Illumina Cluster 3.1.3 being only 47) we found an intersection of 16
Genes (DDX60, IFI35, IFI44, IFI44L, IFIH1, IFIT1, IFIT2, IRF7, ISG15,
Antiviral defense
type I interferon 
signaling pathwayImmunity
defense response to virus
Innate immunity
response to virus

















Ontology GOTERM_BP_DIRECT UP_KEYWORDS Count 6 9 12 15
Fig. 3. Functional enrichment analysis of the identified 88 genes intersecting between
Affymetrix and Illumina search procedures. ‘Antiviral defense’ is the most significant term,
whilst ‘type I interferon signalling pathway’ is the most enriched albeit with a non-significant
p-value.
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Fig. 4. Clustered Illumina interaction network. Illumina models’ selected genes are blue, Affymetrix selected genes are orange, and those intersecting both technologies are pink. (A)
Illumina Interaction network after initial clustering (visualising clusters > 10 Genes). (B) Cluster 3, containing the most selected genes which intersected between Affymetrix and Illumina
models. (B.1) Cluster 3 Enlarged. (C) Highly selected sub clusters of Cluster 3. (D) Cluster 3.4, a sub cluster of Cluster 3 containing two genes which were selected by both Affymetrix and
Illumina models.
MX1, OAS2, SCO2, TIMM10, TRAFD1, TRIM22 and ZBP1) which was
statistically significant (p-value < 3.18e-12), 10 of which known to be
ISGs (IFI35, IFI44, IFI44L, IFIH1, IFIT1, IFIT2, IRF7, ISG15, MX1,
OAS2) (McNab et al., 2015). Performing DAVID enrichment analysis on
both clusters, we find in Illumina Cluster 3.1.3 one highly enriched term
‘type I interferon signalling pathway’ albeit with a non-significant p-value
(Section S3). We do not see the same term in the Affymetrix cluster; how-
ever, it does contain numerous ISGs, which we saw commonly amongst
gene lists. This convergence between independent feature selection across
separate manufacturers and different studies reinforces the high predictive
power of ISGs for discriminating disease state across infection studies.
Independent cluster convergence between Affymetrix and Illu-
mina models. To examine whether convergence between Affymetrix and
Illumina was also to the same clusters containing the same genes we looked
at where in the Illumina interaction network Affymetrix gene lists selected
from (Figure 4, full break down in Section S3). Although selected genes
varied between Affymetrix and Illumina sets, we indeed found that both
converged around the same clusters of genes. Moreover, we found that 19
clusters (including lower level sub clusters) were selected by both Affyme-
trix and Illumina models in the Illumina interaction network. Interestingly
amongst this set, the four sub clusters intersecting across all Illumina gene
lists (all from within the larger Illumina-Cluster 3: Figure 4) were also
selected by Affymetrix gene lists: Illumina-Cluster 3.1.3, Illumina-Cluster
3.1.4, Illumina-Cluster 3.1.5, and Illumina-Cluster 3.4. All of these clu-
sters contained genes revealed by selection frequency analysis in previous
section 4.2. We investigated all four clusters selected by all Illumina models
(Clusters 3.1.3, 3.1.4, 3.1.5 and 3.4) and found they could be separated
functionally to different aspects of an immune response. As mentioned,
enrichment analysis on Illumina Cluster 3.1.3 revealed the ISGs to be
present. However, enrichment analysis also revealed a number of both
highly enriched and significant terms related to viral infections (‘response
to Viruses’, ‘defense response to virus’), and most prominently ‘Antivi-
ral Defense’ which is no surprise given the high number of interferon
related genes in the cluster (Section S3). Comparing the 47 genes in Clu-
sters 3.1.3 to our model frequency analysis revealed 18 overlapping genes
Table 4. Overall optimal model performance. Model performance break
down by Affymetrix and Illumina data sets on the held out test dataset in
terms of final model gene size, Balanced Accuracy, Sensitivity, Specificity,
and Mcnemar’s Test p-value. Mcnemar’s Test p-value indicates whether the
prediction aligns with the true class distribution.
Affymetrix Illumina Average
BW GA BW GA Average
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(DHX58, EPSTI1, HERC5, IFI44, IFI44L, IFI6, IFIT1, IFIT2, IFIT5,
ISG15, MX1, OAS2, OAS3, RSAD2, RTP4, SAMD9, SPATS2L, and
TMEM123). For cluster 3.1.4, in which LY6E resides, it bears relation to
cell signalling with by far the most significant and enriched term ‘chemo-
taxis’ (Section S3). Chemotaxis is well known to play critical role in host
response to infections, and is specifically involved in recruitment of leu-
kocytes, and movement of lymphocytes around the body (Jin et al., 2008).
The intersect of cluster 3.1.4 with our model frequency analysis was also
large, being 12 of its 40 genes (ATF3, CCL2, CXCL10, HERC6, LAMP3,
LGALS3BP, LY6E, OTOF, PARP12, SEPT4, SERPING1, and SIGLEC1).
Cluster 3.1.5 contains genes involved in programmed cell death, contai-
ning several significant and enriched terms like ‘Apoptosis’, ‘Regulation
of apoptotic process’ and ‘apoptotic process’ (Section S3). A total of 3 of
its 37 genes intersected our model frequency analysis (CHMP5, FCGR1A,
and FCGR1B). Illumina cluster 3.4 contained genes more related to general
innate responses with enriched terms containing ‘Inflammatory response’
and ‘innate immune response’ with non-significant p-values (Section S3).
Amongst the genes are a number related to the Toll-like receptor family
(also an enriched and significant term), which respond to microbial produ-
cts and viruses, and are key-receptors of the innate immune system (Das
et al., 2017). Although not visible in the functional enrichment analysis,
Illumina Cluster 3.4 also contained a number of Interleukin genes (IL1B,
IL1R1, IL4R, IL18R1, IRAK3), known to be involved in inflammation
and fundamental to innate immunity (Dinarello, 2011). Out of the 253
genes in cluster 3.4, 15, including CD177, intersected with previous fre-
quency analysis (BATF, CD177, DDAH2, GADD45A, GPR84, GRB10,
GYG1, HK3, IRAK3, MAN2A2, MKNK1, NSUN7, SULT1B1, TSPO,
and ZDHHC19).
Table 5. Illumina interpreted inferred interaction network properties. Clusters
have been labelled either functionally related to the immune response (FR).
For a cluster to be labelled as FR, functional enrichment analysis of their gene
list will have revealed terms both enriched and significant implicated in the


















19839 110 (1.00) 24 (21) 10 (9) 4 (4)
3.4 Cross manufacturer gene list performance
We evaluated each of the BW & GA representative models from Affy-
metrix on the Illumina Data and Illumina Models on the Affymetrix data.
Contrasting each model’s performance between these two discovery and
non-discovery datasets we get the performance results depicted in Figure 5.
This figure shows the difference between overall accuracy, and class-based
accuracy, speciality and sensitivity when generalising our models to data
pertaining from a different technology and set of studies. In terms of ove-
rall accuracy (Figure 5A) Affymetrix models, both GA ad BW, performed
worse when applying to the Illumina data. However, the drop was less
than 0.1 for both Affymetrix GA and BW. Whereas for Illumina, both
GA and BW models slightly gained accuracy when applied to the Affy-
metrix data (0.04 and 0.05 respectively). Looking specifically at bacterial
performance (Figure 5B), both Illumina models performed worse on the
Affymetrix data in terms of bacterial balanced Accuracy (BW_I 0.71 and
GA_I 0.73 2dp). Whereas the Affymetrix models performed well on the
Illumina data (BW_I 0.89 and GA_I 0.89 2dp). In terms of bacterial speci-
ficity there was little change for all models, staying within ± 0.05 2dp of
change in performance. However, in terms of bacterial sensitivity, the Illu-
mina models performed particularly worse on the Affymetrix data (BW_I
0.44 and GA_I 0.47 2dp). Across viral class specific metrics (Figure 5B),
no model had any large change in Balanced Accuracy (change < 0.05
2dp). The largest metric change was seen in sensitivity, with Affymetrix
models slightly decreasing, but with an original score of 0.97 and 0.95
for BW_I and GA_I they are still performing well when ran on the Illu-
mina data. Overall, both Affymetrix and Illumina models performed well
given that data was pertaining from different manufacturers and different
groups of studies. Particularly stability around viral performance suggests
a robustness within the gene lists for classifying viral samples correctly.
However, given that bacterial performance change was very comparable
to viral, it too suggests a strong ability to classify bacterial samples, even

















































Bacterial Specificity Bacterial Sensitivity
Fig. 5. Cross manufacturer model change in performance. Difference in performance when
taking Affymetrix derived models and testing on the Illumina data, and the Illumina derived
models when testing on the Affymetrix data. (A) Difference in performance in terms of
overall Accuracy. (B) Class based performance in terms of Balanced Accuracy, Sensitivity,
and Specificity. For each performance measure, bars are grouped by model, and each bar
refers to the difference between performance on the original dataset (which each model was
discovered on) and the performance on the data it had not been exposed too. For Affymetrix
models this would contrast the performance on the Affymetrix data, with the same model’s
performance on the Illumina data.
4 Discussion
Due to the amount of relevant data, we focused our analysis on studies from
two of the largest microarray platforms, Affymetrix and Illumina. Alth-
ough RNA sequencing data is being currently used to evaluate molecular
responses, the number of publicly available human blood infection samples
is significantly lower than those of microarrays. The technologies used in
this publication utilise very different methods for detecting mRNA sequ-
ences with Affymetrix using a 25bp capture target while Illumina uses a
50bp capture target with very different detection methods. This creates lar-
ger technical differences that cannot be easily removed using mathematical
approaches (Barnes et al., 2005). Simpler solutions are more specifically
justifiable and allow for greater interpretation, which is the motivation for
feature selection amongst models in biological data. We employed two
feature selection algorithms using the Random Forest Classifier over our
data: Backwards Elimination and GALGO – both essentially cutting the
noise and finding the most significant biological variation responsible for
predicting disease state. It is unknown without a brute force search whe-
ther a truly optimal combination of genes has been found, however both
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BW and GA approaches converged around a small group of genes located
in uncorrelated and functionally separable clusters. Models were found to
be strongly enriched for the ISGs. In fact, IFI27 and LY6E (both ISGs)
were included in all Affymetrix and Illumina models. IFI27 is involved in
various signalling pathways affecting apoptosis (Rosebeck and Leaman,
2008; Liu et al., 2014; Gytz et al., 2017). Whereas, LY6E belongs to a
class of interferon-inducible factors that broadly enhance viral infectivity
(Mar et al., 2018). LY6E has also been attributed a diverse set of effects,
including attenuating T-cell receptor signalling (Saitoh et al., 1995) and
suppressing responsiveness to lipopolysaccharide which stimulate immune
responses (Meng and Lowell, 1997). Moreover, IFI27 was shown by Tang
et al. to be a single–gene biomarker that discriminates between influenza,
and other viral and bacterial infections in patients with suspected respi-
ratory infection (Tang et al., 2017). However, this single-gene biomarker
approach lacks generalisability and robustness when predicting a more
varied pathogen set. As we have observed, performance in our meta-
analysis was greatly improved by including more genes in our models.
While Sweeney et al. employed a more multivariate approach their 7 gene
strong model only marginally was able to discriminate between bacte-
rial and viral classes in our dataset (Section S5). More specifically, we
asked the question whether the resulting score was able to discriminate
between bacterial, control, and viral samples and found that while on ave-
rage these 7 genes discriminated between viral and bacterial samples a
technology dependent threshold is required to optimally separate the clas-
ses (Figure S24 and S25). Moreover, control samples generally scored
similarly to bacterial samples. In a secondary attempt we tried to utilise
the same RF approach using the 7 genes provided by the authors and
found that in all cases specificity in the model was high but sensitivity
was significantly lower than the models we have developed (Tables S32-
S37). Our larger set of RF selected genes contained numerous examples
confirmed by previous studies to be implicated in disease states. For insta-
nce, our results coincide with recent meta-analysis, by Andres-Terre et al.,
looking at transcriptional signatures of infections, specifically in distingui-
shing influenza from other viral and bacterial infections, which found 127
multi-gene signatures, 27 of which were also present in our representa-
tive models (ATF3, BST2, CXCL10, EIF2AK2, HERC5, HERC6, IFI27,
IFI44, IFI44L, IFI6, IFIT1, IFIT2, IFIT5, ISG15, JUP, LGALS3BP, LY6E,
MRPL44, MTHFD2, MX1, OAS1, OAS2, OAS3, OASL, RSAD2, RTP4,
SERPING1, SPATS2L) serving to validate our successful data integration
and biological findings (Andres-Terre et al., 2015). Notably amongst these
coinciding genes are IFI27 and LY6E, again confirming the validity of our
converging feature selection. To better understand the genes selected by
our approach we directly compared the 88 genes that were selected on the
basis of having a> 5% inclusion rate (Figure S14). Notably between Affy-
metrix and Illumina data, the direction of change (up or down-regulation)
comparing bacterial, control, and viral samples was retained with some
clear differences in variation for a subset of genes likely due to the tech-
nological differences between the platforms. For example, the gene XIST
shows high variability in the Affymetrix dataset and a smaller magnitude
of variation within the Illumina data but with a consistent change in the
medians across the samples (Figure S14). Similarly, IFI27, one of the key
genes identified by our and other authors shows similar response mech-
anics although with a marginally higher level of expression in Illumina
datasets. Overall, the responses, regardless of the two technologies tested,
are comparable and contribute to the ability to develop a cross-technology
predictive model. By inferring the underlying interaction network, we
discovered that convergence was not only happening to a set of genes,
but also, and more prominently, convergence was focusing around parti-
cular groups of functionally similar genes. This gene-group convergence
only emerged as part of an in-depth investigation into the driving forces of
feature selection from a biological network perspective. When representa-
tive members of these uncorrelated gene clusters are taken together, they
can form highly predictive gene lists. With the ability to define the host
response to viral and bacterial infections, genes of our identified clusters
are likely good at approximating key functions important in disease state
prediction. Notably, the four functional groups of genes were indicated
to be: Type I interferon-inducible genes (ISGs), Chemotaxis genes, Apo-
ptotic Processes genes, and Inflammatory / Innate Response genes, which
were prevalent in every model (both Affymetrix and Illumina). Within this
cluster convergence we found a highly selected group of genes to be ISGs
(the most frequent between both Affymetrix and Illumina models). This is
no surprise, given Type I Interferons serve as a link between the innate and
adaptive immune systems (Tough, 2004) and have a broad range of effects
on both innate and adaptive immune cells during infection with viruses,
bacteria, and parasites (McNab et al., 2015). While ISGs exact function
are not fully understood, it appears our RF models have identified their
strong connection to disease state (Hertzog et al., 2003; Kovarik et al.,
2016). Whilst convergence was prominent around four functional groups
of genes, we also note that both in Affymetrix and Illumina, a more vari-
able set of functional gene groups were used in addition within our gene
lists. Hence, there is a degree of variability in gene solutions, and it seems
there is an interchangeable portion of our gene lists in which a number of
genes from uncorrelated functional groups of genes can be used to achieve
high performance in defining disease state. Finally, we verified our gene
lists for generalisability by retraining and evaluating on data from a dif-
ferent manufacturer to which they were discovered in (Affymetrix Gene
lists to Illumina and Illumina Gene lists to Affymetrix). It is apparent that
all gene lists tend to do better on Affymetrix data, regardless of which
set they were discovered on, which suggests that the dataset, not the gene
lists, is influencing performance. Hence, we have uncovered the differen-
tiating biological signatures underlying able to define bacterial and viral
infections.
5 Conclusion
With the high accuracy that our models achieve within these datasets,
stratification and treatment options for relevant individuals can be easily
improved through the use of such models. To apply this in clinical settings
across larger populations additional development of a cheap diagnostic
test, for example using PCR or Nanostring, would be required. Impor-
tantly, the increase in costs associated with such an initial diagnostic test
would be significantly offset by more rationale use of antibiotics in clinical
settings and could potentially mitigate the increasingly observed antibiotic
resistance. To tackle this challenge, we need to establish better diagnostic
tools, linked to computational mechanisms, to provide a more compreh-
ensive detection of diseases and associated treatments. Such personalised
medicine approaches can only be supported with models such as develo-
ped within this publication. As data availability is growing and healthcare
is transforming into the digital age, it is conceivable that our model will
have a place in supporting clinical decisions at some point in the future.
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